These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17568048)

  • 1. Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey.
    Davaalkham D; Ojima T; Wiersma S; Lkhagvasuren T; Nymadawa P; Uehara R; Watanabe M; Oki I; Nakamura Y
    J Epidemiol Community Health; 2007 Jul; 61(7):578-84. PubMed ID: 17568048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiology of hepatitis B virus infection among children in Mongolia: results of a nationwide survey.
    Davaalkham D; Ojima T; Nymadawa P; Tsend N; Lkhagvasuren T; Wiersma S; Uehara R; Watanabe M; Oki I; Nakamura Y
    Pediatr Int; 2007 Jun; 49(3):368-74. PubMed ID: 17532838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.
    Black AP; Nouanthong P; Nanthavong N; Souvannaso C; Vilivong K; Jutavijittum P; Samountry B; Lütteke N; Hübschen JM; Goossens S; Quet F; Buisson Y; Muller CP
    BMC Infect Dis; 2014 Aug; 14():457. PubMed ID: 25149478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
    BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the universal hepatitis B immunization program in Mongolia: achievements and challenges.
    Davaalkham D; Ojima T; Uehara R; Watanabe M; Oki I; Wiersma S; Nymadawa P; Nakamura Y
    J Epidemiol; 2007 May; 17(3):69-75. PubMed ID: 17545693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness of plasma-derived hepatitis B vaccine 22-28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed?
    Li H; Li GJ; Chen QY; Fang ZL; Wang XY; Tan C; Yang QL; Wang FZ; Wang F; Zhang S; Bi SL; Shen LP
    Epidemiol Infect; 2017 Apr; 145(5):887-894. PubMed ID: 28065199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study.
    Hiva S; Negar K; Mohammad-Reza P; Gholam-Reza G; Mohsen A; Ali-Asghar NG; Mohammed-Jafar S
    BMC Public Health; 2020 Jun; 20(1):920. PubMed ID: 32532228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of hepatitis B vaccination into rural African primary health care programmes.
    Schoub BD; Johnson S; McAnerney JM; Blackburn N; Kew MC; McCutcheon JP; Carlier ND
    BMJ; 1991 Feb; 302(6772):313-6. PubMed ID: 1825799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.
    Hanna JN; Faoagali JL; Buda PJ; Sheridan JW
    J Paediatr Child Health; 1997 Feb; 33(1):67-70. PubMed ID: 9069048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study examining hepatitis B virus infection and immunization rates in Northwest China.
    Ji Z; Wang T; Shao Z; Huang D; Wang A; Guo Z; Long Y; Zhang L; Su H; Zhang Q; Yan Y; Fan D
    PLoS One; 2014; 9(5):e97474. PubMed ID: 24832483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete protection against hepatitis B among remote Aboriginal adolescents despite full vaccination in infancy.
    Dent E; Selvey CE; Bell A; Davis J; McDonald MI
    Commun Dis Intell Q Rep; 2010 Dec; 34(4):435-9. PubMed ID: 21413528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional serosurvey on hepatitis B vaccination uptake among adult patients from GP practices in a region of South-West Poland.
    Ganczak M; Dmytrzyk-Daniłów G; Korzeń M; Szych Z
    BMC Public Health; 2015 Oct; 15():1060. PubMed ID: 26475167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
    Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
    Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18.
    Murhekar MV; Santhosh Kumar M; Kamaraj P; Khan SA; Allam RR; Barde P; Dwibedi B; Kanungo S; Mohan U; Mohanty SS; Roy S; Sagar V; Savargaonkar D; Tandale BV; Topno RK; Girish Kumar CP; Sabarinathan R; Bitragunta S; Grover GS; Lakshmi PVM; Mishra CM; Sadhukhan P; Sahoo PK; Singh SK; Yadav CP; Kumar R; Dutta S; Toteja GS; Gupta N; Mehendale SM;
    Int J Infect Dis; 2020 Nov; 100():455-460. PubMed ID: 32896662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy.
    Scognamiglio P; Girardi E; Fusco M; Piselli P; Spena SR; Maione C; Pisanti FA; Serraino D;
    BMC Infect Dis; 2009 Jun; 9():86. PubMed ID: 19500412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
    Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B (HB) immunoglobulin plus HB vaccine for intrauterine HB virus infection.
    Iwasawa K; Inui A; Tsunoda T; Kondo T; Kawamoto M; Sogo T; Komatsu H; Fujisawa T
    Pediatr Int; 2015 Jun; 57(3):401-5. PubMed ID: 25331640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.